Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Diagnostic value of TL-201 lung uptake is dependent on measurement method
Authors
Anne Hitzel
Alain Manrique
Alain Cribier
Pierre Véra
Publication date
01-05-2001
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2001
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1067/mnc.2001.113515

Other articles of this Issue 3/2001

Journal of Nuclear Cardiology 3/2001 Go to the issue

Editorials

what is wrong with the treadmill exercise test?

Editorial

F-18 fluorodeoxyglucose imaging in myocardial ischemia: Beyond myocardial viability

OriginalPaper

Optimal 3-dimensional method for right and left ventricular Fourier phase analysis in electrocardiography-gated blood-pool SPECT

OriginalPaper

Detection of a large substernal goiter during Tc-99m tetrofosmin cardiac SPECT imaging

OriginalPaper

Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET

OriginalPaper

Day-to-day reproducibility of mental stress-induced abnormal left ventricular function response in patients with coronary artery disease and its relationship to autonomic activation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits